Telmisartan vs losartan in hypertensive patients with impaired glucose tolerance: A comparison of their antihypertensive, metabolic, and vascular effects.

Trial Profile

Telmisartan vs losartan in hypertensive patients with impaired glucose tolerance: A comparison of their antihypertensive, metabolic, and vascular effects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Mar 2010

At a glance

  • Drugs Losartan (Primary) ; Telmisartan (Primary)
  • Indications Diabetes mellitus; Glucose intolerance; Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top